Article summary
This 12-month follow-up study (n=25) of male US Special Operations Veterans with traumatic brain injury (TBI) found that reductions in disability, PTSD, depression and anxiety symptoms after a single magnesium-ibogaine treatment were largely maintained over the year. Most participants also used other psychedelics or treatments during follow-up, so the improvements cannot be attributed to ibogaine alone.
Continue to the original publication for the complete article.